|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.000 HKD | 0.00% |
|
-6.54% | +25.00% |
| 26/06 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| 19/06 | Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors | MT |
| Market Cap | 64Cr 74Cr 9.43Cr 8.25Cr 7.6Cr 7.05Cr 13Cr 894.69Cr 14Cr 91Cr 35Cr 441.55Cr 35Cr 35Cr 1.53TCr | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 86Cr 100Cr 13Cr 11Cr 10Cr 9.49Cr 18Cr 1.2TCr 18Cr 122.76Cr 48Cr 594.58Cr 48Cr 47Cr 2.06TCr | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -6.54% | ||
| Current month | -6.54% | ||
| 1 month | -4.76% | ||
| 3 months | -21.26% | ||
| 6 months | +26.58% | ||
| Current year | +25.00% |
| 1 week | 0.94 |  | 1.07 |
| 1 month | 0.91 | | 1.11 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/24/19 | Other | Chairman | 6,50,000 | 0.0867% | ||
| 18/24/18 | Other | Chairman | 2,40,000 | 0.0320% | ||
| 18/24/18 | Other | Chairman | 2,40,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.54% | +163.16% | -22.48% | 9.43Cr | |
| -0.80% | +1.38% | +12.40% | +82.31% | 4.81TCr | |
| -3.08% | +3.29% | +65.80% | +113.96% | 3.74TCr | |
| -1.38% | -2.29% | -5.21% | +40.28% | 1.24TCr | |
| -0.43% | +3.18% | +14.94% | +97.17% | 1.21TCr | |
| +0.77% | +2.76% | +34.19% | +120.25% | 914.06Cr | |
| -2.85% | -1.00% | +18.82% | +43.73% | 721.44Cr | |
| +1.24% | +4.23% | +58.03% | -1.50% | 713.58Cr | |
| -1.82% | +0.88% | +19.55% | +222.63% | 673.45Cr | |
| -2.81% | +17.66% | -18.38% | +20.93% | 635.09Cr | |
| Average | -1.12% | +2.99% | +36.33% | +71.73% | 1.47TCr | |
| Weighted average by Cap. | -1.44% | +3.81% | +27.72% | +88.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33Cr 38Cr 4.8Cr 4.2Cr 3.87Cr 3.59Cr 6.81Cr 455.38Cr 6.92Cr 46Cr 18Cr 224.74Cr 18Cr 18Cr 776.79Cr | 27Cr 32Cr 4.02Cr 3.52Cr 3.24Cr 3.01Cr 5.71Cr 381.82Cr 5.8Cr 39Cr 15Cr 188.44Cr 15Cr 15Cr 651.32Cr |
| Net income | -19Cr -22Cr -2.78Cr -2.43Cr -2.24Cr -2.08Cr -3.94Cr -263.68Cr -4.01Cr -27Cr -10Cr -130.13Cr -10Cr -10Cr -449.79Cr | -1.18Cr -1.36Cr -17.34L -15.18L -13.99L -12.96L -24.61L -16Cr -25.01L -1.68Cr -65.22L -8.12Cr -65.11L -63.7L -28Cr |
| Net Debt | 37Cr 42Cr 5.4Cr 4.73Cr 4.36Cr 4.04Cr 7.67Cr 512.94Cr 7.79Cr 52Cr 20Cr 253.15Cr 20Cr 20Cr 874.99Cr | 22Cr 26Cr 3.27Cr 2.86Cr 2.63Cr 2.44Cr 4.64Cr 310.07Cr 4.71Cr 32Cr 12Cr 153.02Cr 12Cr 12Cr 528.92Cr |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | HK$1.000 | 0.00% | 0 |
| 07/26/07 | HK$1.000 | -0.99% | 6,000 |
| 06/26/06 | HK$1.010 | 0.00% | 95,000 |
| 03/26/03 | HK$1.010 | +7.45% | 17,000 |
| 02/26/02 | HK$0.9400 | -12.15% | 1,84,000 |
- Stock Market
- Stocks
- 1652 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
